Philippines - English - FDA (Food And Drug Administration)

inphilco, inc.; distributor: inphilco, inc. - chlortetracycline hydrochloride (vet.) - aerosol spray - 3.21 g

Philippines - English - FDA (Food And Drug Administration)

inphilco, inc.; distributor: inphilco, inc. - oxytetracycline (as dihydrate) (vet.) - solution for injection (im/sc) - 200 mg/ml

United States - English - NLM (National Library of Medicine)

warner chilcott pharmaceuticals inc. - risedronate sodium (unii: ofg5exg60l) (risedronic acid - unii:km2z91756z) - risedronate sodium 150 mg - actonel is indicated for the treatment and prevention of osteoporosis in postmenopausal women. in postmenopausal women with osteoporosis, actonel reduces the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures [see clinical studies (14.1, 14.2) ]. actonel is indicated for treatment to increase bone mass in men with osteoporosis. actonel is indicated for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoid treatment (daily dosage of ≥ 7.5 mg prednisone or equivalent) for chronic diseases. patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin d. actonel is indicated for treatment of paget’s disease of bone in men and women. - abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia [see warnings and precautions (5.1) ] - inability to stand or sit upright for at least 30 minutes [see dosage

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: amb hk enterprises inc.; distributor: amb hk enterprises inc. - methylprednisolone - tablet - 16 mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: amb hk enterprises inc.; distributor: amb hk enterprises inc. - methylprednisolone - tablet - 4 mg

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - oxycodone hydrochloride 2.5 mg - oxycodone and acetaminophen tablets, usp are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve oxycodone and acetaminophen tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia oxycodone and acetaminophen tablets are contraindicated in patients with:  - significant respiratory depression [see warnings ] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings ] - known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings ] - hypersensitivity to oxycodone, acetaminophen, or any other component of the produc

United States - English - NLM (National Library of Medicine)

warner chilcott (us), inc. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline - unii:n12000u13o) - capsule, delayed release pellets - 100 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of doryx and other antibacterial drugs, doryx should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections: doxycycline is also indicated for the treatment of infections caused by the following gram-negative microorganisms: because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended. doxycycline is indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriological testing indicates appropri

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unam pharmaceutical (m) sdn bhd - lactoferrin; d-alpha tocopheryl acetate; zinc gluconate -

United States - English - NLM (National Library of Medicine)

mckesson rxpak inc - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - hydrocodone bitartrate 10 mg - norco® is indicated for the management of moderate to moderately severe pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve norco® for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia norco® is contraindicated in patients with: - significant respiratory depression [see warnings ] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings ] - patients who have previously exhibited hypersensitivity to hydrocodone or acetaminophen. - known hypersensitivity to other opioids who may exhibit cross-sensitivity to hydrocodone. norco® contains hydrocodone, a schedule ii controlled s

United States - English - NLM (National Library of Medicine)

mckesson rxpak inc - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - hydrocodone bitartrate 10 mg - norco® is indicated for the management of moderate to moderately severe pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve norco® for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia norco® is contraindicated in patients with: - significant respiratory depression [see warnings ] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings ] - patients who have previously exhibited hypersensitivity to hydrocodone or acetaminophen. - known hypersensitivity to other opioids who may exhibit cross-sensitivity to hydrocodone. norco® contains hydrocodone, a schedule ii controlled s